Schwan: Roche to pursue 'targeted acquisitions'

Roche isn't pursuing any large deals, especially ones the size of Abbott Labs' ($ABT) recently announced overhaul, CEO Severin Schwan (photo) said in an interview. "We are not interested in mega-mergers. We are interested in very targeted acquisitions which complement our technologies and portfolios," he explained. News

Suggested Articles

California CDMO JSR Life Sciences is building a new home for two subsidiaries as it hopes to enter the competitive biologics market.

Three facts about how distributors are managing in-demand inventory.

Novartis’ latest campaign with a celebrity dance partner asks people to bust a move to raise awareness around sickle cell anemia and therapy Adakveo.